Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 33

Sort by

Sort Order Select

Journal Articles

Factors Associated with Catheter-Related Thrombosis in Autologous Stem Cell Transplant Patients: Can We Predict Risk?

Annie M. Jacobsen, MD, Qing Cao, MS, Veronika Bachanova, MD PhD, Surbhi Shah, MD

Blood (2020) 136 (Supplement 1): 28–29.

https://doi.org/10.1182/blood-2020-139682

Published: 2020

Journal Articles

Plasma Short Chain Fatty Acids As a Predictor of Response to Therapy for Life-Threatening Acute Graft-Versus-Host Disease

Parth Gandhi, Isha Gandhi, Andrea Hoeschen, Wes Mosher, Margaret L. MacMillan, MD, Armin Rashidi, MD PhD, Najla H El Jurdi, MD, Alexander Khoruts, MD, Daniel J. Weisdorf, MD, Bruce R. Blazar, MD, Qing Cao, MS, Brian C. Betts, MD, Angela Panoskaltsis-Mortari, PhD, Chi Chen, Shernan G Holtan, MD

Blood (2020) 136 (Supplement 1): 14.

https://doi.org/10.1182/blood-2020-140117

Published: 2020

Journal Articles

Results of a Phase 1 Trial of Gda-201, Nicotinamide-Expanded Allogeneic Natural Killer (NK) Cells in Patients with Refractory Non-Hodgkin Lymphoma (NHL) and Multiple Myeloma

Veronika Bachanova, MD PhD, Joseph Maakaron, MD, David H. McKenna, MD, Qing Cao, MS, Todd E. DeFor, MS, Fiona He, MD, Murali Janakiram, MD, Rose Wangen, Zuzan Cayci, MD, Bartosz Grzywacz, MD, Ronit Simantov, MD, Tracey Lodie, PhD, Jeffrey S. Miller, MD

Blood (2020) 136 (Supplement 1): 6.

https://doi.org/10.1182/blood-2020-142419

Published: 2020

Journal Articles

5 Year Health Care Burden after Allogeneic Hematopoietic Stem Cell Transplantation (HSCT): Impact of Graft Source

Jesus Garcia Garcia, BS, Sonya Grillo, Qing Cao, MS, Claudio G Brunstein, MD PhD, Mukta Arora, MD, Margaret L. MacMillan, MD, John E. Wagner, MD, Daniel J. Weisdorf, MD, Shernan G. Holtan, MD

Blood (2018) 132 (Supplement 1): 367.

https://doi.org/10.1182/blood-2018-99-113201

Published: 2018

Journal Articles

Facilitating Resolution of Life-Threatening Acute Graft-Versus-Host Disease By Supplementation of Human Chorionic Gonadotropin and Epidermal Growth Factor (Pregnyl): A Phase I Study

Blood (2018) 132 (Supplement 1): 71.

https://doi.org/10.1182/blood-2018-99-113564

Published: 2018

Journal Articles

Immune Mediated Cytopenias Following Allogeneic Hematopoietic Cell Transplantation for Non-Malignant Disease: Risk Factors and Treatment Response in the Pediatric Population

Robert T. Galvin, MD, Qing Cao, MS, Weston P. Miller, MD, Angela R. Smith, MD MS, Christen L. Ebens, MD MPH

Blood (2018) 132 (Supplement 1): 3377.

https://doi.org/10.1182/blood-2018-99-117718

Published: 2018

Journal Articles

Catheter-Related Thrombosis in Patients with Lymphoma or Myeloma Undergoing Autologous Stem Cell Transplantation

Livia Hegerova, MD, Adam Bachan, Qing Cao, MS, Veronika Bachanova, MD PhD, Mark Reding, MD, John Rogosheske, PharmD, Brian McClune, DO, Aleksandr Lazaryan, MD PhD MPH, Greg M Vercellotti, MD FACP, Huong X Vu, PharmD

Blood (2017) 130 (Supplement 1): 3695.

https://doi.org/10.1182/blood.V130.Suppl_1.3695.3695

Published: 2017

Journal Articles

High Peripheral Blood Stem Cell (PBSC) CD34+ Cell Dose Increases the Risk of Chronic Gvhd after Human Leukocyte Antigen (HLA) Matched Sibling Transplantation

Ezzideen Barjes Alrawi, MD, Erica D. Warlick, MD, Qing Cao, MS, Mukta Arora, MD, Shernan G. Holtan, MD, Tim Krepski, Michael R. Verneris, MD, John Wagner, Daniel J. Weisdorf, MD, Claudio G Brunstein, MD

Blood (2016) 128 (22): 5877.

https://doi.org/10.1182/blood.V128.22.5877.5877

Published: 2016

Journal Articles

Umbilical Cord Blood Transplantation and Delay Engraftment Are Associated with Increased Risks of Diffuse Alveolar Hemorrhage

Ezzideen Barjes Alrawi, MD, Fatma Keklik., MD, Qing Cao, MS, Nelli Bejanyan, MD, Margaret L. MacMillan, MD, Mukta Arora, MD, Erica D. Warlick, MD, Claudio G Brunstein, MD, Daniel J. Weisdorf, MD, Celalettin Ustun, MD

Blood (2016) 128 (22): 2222.

https://doi.org/10.1182/blood.V128.22.2222.2222

Published: 2016

Journal Articles

Monocyte Subpopulation Recovery and Outcomes Following Hematopoietic Cell Transplantation

Lucie M. Turcotte, MD, Qing Cao, MS, Elias Krahn, Julie Curtsinger, PhD, Ashley M. Yingst, MS, Sarah Cooley, MD, Claudio G Brunstein, MD, Margaret L. MacMillan, MD, Shernan G. Holtan, MD, John E. Wagner, MD, Daniel J. Weisdorf, MD, Bruce R. Blazar, MD, Jeffrey S. Miller, MD, Michael R. Verneris, MD

Blood (2016) 128 (22): 2232.

https://doi.org/10.1182/blood.V128.22.2232.2232

Published: 2016

Journal Articles

Day 21 Chimerism Is a Critical Prognostic Factor for Graft Failure and Survival in Recipients of Myeloablative Conditioning and Umbilical Cord Blood (UCB) Transplantation

Nelli Bejanyan, MD, Claudio G Brunstein, MD, Qing Cao, MS, Bharat Thyagarajan, MD PhD, Karamjeet S. Sandhu, MD, Mukta Arora, MD MS, Daniel J. Weisdorf, MD, John E Wagner, MD

Blood (2014) 124 (21): 3867.

https://doi.org/10.1182/blood.V124.21.3867.3867

Published: 2014

Journal Articles

Pharmacokinetic Modeling of Fludarabine to Control Exposure and Improve Outcomes after Reduced Intensity Conditioning Transplantation

Kinjal Sanghavi, M Pharm, Anthony C. Wiseman, MD, Qing Cao, MS, Erica D. Warlick, MD, Claudio G Brunstein, MD, Richard Brundage, PharmD PhD, John Rogosheske, PharmD, Andy Kurtzweil, PharmD, John E. Wagner, MD, Daniel J. Weisdorf, MD, Pamala A. Jacobson, PharmD

Blood (2014) 124 (21): 3869.

https://doi.org/10.1182/blood.V124.21.3869.3869

Published: 2014

Journal Articles

Remission Induction in a Phase 1 Study of a Bispecific Single Chain Immunotoxin Targeting CD22 and CD19 (DT2219) for Refractory B-Cell Malignancies

Veronika Bachanova, MD, Arthur Frankel, Qing Cao, MS, Dixie Lewis, Michael Verneris, MD, Aleksandr Lazaryan, MD PhD MPH, Linda J. Burns, MD, Daniel Vallera, PhD

Blood (2014) 124 (21): 3098.

https://doi.org/10.1182/blood.V124.21.3098.3098

Published: 2014

Journal Articles

Association of Cyclophosphamide (CY) and Fludarabine (FLU) Pharmacokinetics with Treatment Related Mortality (TRM) after Reduced Intensity Conditioning (RIC) Hematopoietic Cell Transplantation (HCT)

Anthony C. Wiseman, MD, Kinjal Sanghavi, M Pharm, Qing Cao, MS, Erica D. Warlick, MD, Claudio G Brunstein, MD, John Rogosheske, PharmD, Andy Kurtzweil, PharmD, Daniel J. Weisdorf, MD, Pamala A. Jacobson, PharmD

Blood (2014) 124 (21): 1153.

https://doi.org/10.1182/blood.V124.21.1153.1153

Published: 2014

Journal Articles

Acute Graft Versus Host Disease after Donor Lymphocyte Infusion: A Single Center Analysis

Fiona C. He, MD, Daniel J. Weisdorf, MD, Erica D. Warlick, MD, Jeffrey S. Miller, MD, Shernan G. Holtan, MD, Michael R. Verneris, MD, Qing Cao, MS, Margaret L. MacMillan, MD

Blood (2014) 124 (21): 5807.

https://doi.org/10.1182/blood.V124.21.5807.5807

Published: 2014

Journal Articles

Phosphoramide Mustard As a Biomarker Of Cyclophosphamide Exposure In Adults Receiving Reduced Intensity Conditioning Hematopoietic Cell Transplantation

Anthony C. Wiseman, BS, Sanghavi Kinjal, BS, MS, Claudio Brunstein, MD, Erica D. Warlick, MD, Daniel J. Weisdorf, MD, Qing Cao, MS, John Rogosheske, PharmD, Pamala A. Jacobson

Blood (2013) 122 (21): 5461.

https://doi.org/10.1182/blood.V122.21.5461.5461

Published: 2013

Journal Articles

Higher CSA Levels After Umbilical Cord Blood Transplant For Acute Leukemia Result In Improved Survival

Heather E Stefanski, MD, PhD, Michael J Burke, MD, Qing Cao, MS, Angela R. Smith, MD, MS, Margaret L. MacMillan, MD, Erica D. Warlick, MD, Daniel J. Weisdorf, MD, John E. Wagner, MD, Michael R. Verneris, MD

Blood (2013) 122 (21): 2097.

https://doi.org/10.1182/blood.V122.21.2097.2097

Published: 2013

Journal Articles

Autologous and Allogeneic Donor Transplantation for Mantle Cell Lymphoma in Rituximab Era: Impact of Pre-Transplant Burden On Survival.

Erik A Magnusson, MS, Qing Cao, MS, Michael A. Linden, MD, PhD, Linda J Burns, MD, Daniel J. Weisdorf, MD, Veronika Bachanova, MD

Blood (2012) 120 (21): 3092.

https://doi.org/10.1182/blood.V120.21.3092.3092

Published: 2012

Journal Articles

Positive Positron Emission Tomography (PET) Scan in Non-Hodgkin Lymphoma Pre-Transplant Had No Impact On Relapse and Survival After Allogenenic Transplantation

Veronika Bachanova, MD, Celalettin Ustun, MD, Qing Cao, MS, Froelich Jerry, MD, Linda J Burns, MD

Blood (2012) 120 (21): 1999.

https://doi.org/10.1182/blood.V120.21.1999.1999

Published: 2012

Journal Articles

Increased Relapse Associated with Mixed Donor-Donor Chimerism Following Double Umbilical Cord Blood Transplantation (dUCBT)

Michael R. Verneris, MD, Lucie M. Turcotte, MD, Qing Cao, MS, Margaret L. MacMillan, MD, Jeffrey S. Miller, MD, Daniel Weisdorf, MD, Claudio G Brunstein, MD, John E. Wagner, MD

Blood (2012) 120 (21): 358.

https://doi.org/10.1182/blood.V120.21.358.358

Published: 2012

NARROW

Factors Associated with Catheter-Related Thrombosis in Autologous Stem Cell Transplant Patients: Can We Predict Risk?

Plasma Short Chain Fatty Acids As a Predictor of Response to Therapy for Life-Threatening Acute Graft-Versus-Host Disease

Results of a Phase 1 Trial of Gda-201, Nicotinamide-Expanded Allogeneic Natural Killer (NK) Cells in Patients with Refractory Non-Hodgkin Lymphoma (NHL) and Multiple Myeloma

5 Year Health Care Burden after Allogeneic Hematopoietic Stem Cell Transplantation (HSCT): Impact of Graft Source

Facilitating Resolution of Life-Threatening Acute Graft-Versus-Host Disease By Supplementation of Human Chorionic Gonadotropin and Epidermal Growth Factor (Pregnyl): A Phase I Study

Immune Mediated Cytopenias Following Allogeneic Hematopoietic Cell Transplantation for Non-Malignant Disease: Risk Factors and Treatment Response in the Pediatric Population

Catheter-Related Thrombosis in Patients with Lymphoma or Myeloma Undergoing Autologous Stem Cell Transplantation

High Peripheral Blood Stem Cell (PBSC) CD34+ Cell Dose Increases the Risk of Chronic Gvhd after Human Leukocyte Antigen (HLA) Matched Sibling Transplantation

Umbilical Cord Blood Transplantation and Delay Engraftment Are Associated with Increased Risks of Diffuse Alveolar Hemorrhage

Monocyte Subpopulation Recovery and Outcomes Following Hematopoietic Cell Transplantation

Day 21 Chimerism Is a Critical Prognostic Factor for Graft Failure and Survival in Recipients of Myeloablative Conditioning and Umbilical Cord Blood (UCB) Transplantation

Pharmacokinetic Modeling of Fludarabine to Control Exposure and Improve Outcomes after Reduced Intensity Conditioning Transplantation

Remission Induction in a Phase 1 Study of a Bispecific Single Chain Immunotoxin Targeting CD22 and CD19 (DT2219) for Refractory B-Cell Malignancies

Association of Cyclophosphamide (CY) and Fludarabine (FLU) Pharmacokinetics with Treatment Related Mortality (TRM) after Reduced Intensity Conditioning (RIC) Hematopoietic Cell Transplantation (HCT)

Acute Graft Versus Host Disease after Donor Lymphocyte Infusion: A Single Center Analysis

Phosphoramide Mustard As a Biomarker Of Cyclophosphamide Exposure In Adults Receiving Reduced Intensity Conditioning Hematopoietic Cell Transplantation

Higher CSA Levels After Umbilical Cord Blood Transplant For Acute Leukemia Result In Improved Survival

Autologous and Allogeneic Donor Transplantation for Mantle Cell Lymphoma in Rituximab Era: Impact of Pre-Transplant Burden On Survival.

Positive Positron Emission Tomography (PET) Scan in Non-Hodgkin Lymphoma Pre-Transplant Had No Impact On Relapse and Survival After Allogenenic Transplantation

Increased Relapse Associated with Mixed Donor-Donor Chimerism Following Double Umbilical Cord Blood Transplantation (dUCBT)

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only